Induction of Antigen-Specific Tumor Immunity by Genetic and Cellular Vaccines against MAGE: Enhanced Tumor Protection by Coexpression of Granulocyte-Macrophage Colony-Stimulating Factor and B7-1 (original) (raw)
Bakker AB, Schreurs MW, de Boer AJ, et al. (1994). Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med.179: 1005–1009. ArticleCASPubMed Google Scholar
Boel P, Wildmann C, Sensi ML, et al. (1995). BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity2: 167–175. ArticleCASPubMed Google Scholar
Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. (1994). Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol.12: 337–365. ArticleCASPubMed Google Scholar
Brichard V, Van Pel A, Wolfel T, et al. (1993). The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med.178: 489–495. ArticleCASPubMed Google Scholar
Castelli C, Storkus WJ, Maeurer MJ, et al. (1995). Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. J. Exp. Med.181: 363–368. ArticleCASPubMed Google Scholar
Cox AL, Skipper J, Chen Y, et al. (1994). Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science264: 716–719. ArticleCASPubMed Google Scholar
Gaugier B, Van den Eynde B, van der Bruggen P, et al. (1994). Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med.179: 921–930. Article Google Scholar
Kawakami Y, Eliyahu S, Delgado CH, et al. (1994). Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. U.S.A.91: 3515–3519. ArticleCASPubMedPubMed Central Google Scholar
Van den Eynde B, Peeters O, De Backer O, Gaugier B, Lucas S, Boon T. (1995). A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med.182: 689–698. ArticlePubMed Google Scholar
van der Bruggen P, Traversari C, Chomez P, et al. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science254: 1643–1647. ArticlePubMed Google Scholar
De Plaen E, Arden K, Traversari C, et al. (1994). Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics40: 360–369. ArticleCASPubMed Google Scholar
Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP. (1995). Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. U.S.A.92: 4987–4991. ArticleCASPubMedPubMed Central Google Scholar
Patard JJ, Brasseur F, Gil-Diez S, et al. (1995). Expression of MAGE genes in transitional-cell carcinomas of the urinary bladder. Int. J. Cancer64: 60–64. ArticleCASPubMed Google Scholar
Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C. (1995). Expression of the MAGE gene family in primary and metastatic human breast cancer: Implications for tumor antigen-specific immunotherapy. Int. J. Cancer64: 216–221. ArticleCASPubMed Google Scholar
Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. (1995). Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res.55: 3478–3482. PubMedCAS Google Scholar
Amar-Costesec A, Godelaine D, Stockert E, van der Bruggen P, Beaufay H, Chen YT. (1994). The tumor protein MAGE-1 is located in the cytosol of human melanoma cells. Biochem. Biophys. Res. Commun.204: 710–715. ArticleCASPubMed Google Scholar
Kocher T, Schultz-Thater E, Gudat F, et al. (1995). Identification and intracellular location of MAGE-3 gene product. Cancer Res.55: 2236–2239. PubMedCAS Google Scholar
Schultz-Thater E, Juretic A, Dellabona P, et al. (1994). MAGE-1 gene product is a cytoplasmic protein. Int. J. Cancer59: 435–439. ArticleCASPubMed Google Scholar
Traversari C, van der Bruggen P, Luescher IF, et al. (1992). A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med.176: 1453–1457. ArticleCASPubMed Google Scholar
van der Bruggen P, Bastin J, Gajewski T, et al. (1994). A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol24: 3038–3043. ArticlePubMed Google Scholar
van der Bruggen P, Szikora JP, Boel P, et al. (1994). Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol24: 2134–2140. ArticlePubMed Google Scholar
Hoon DS, Yuzuki D, Hayashida M, Morton DL. (1995). Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J. Immunol154: 730–737. PubMedCAS Google Scholar
Mukherji B, Chakraborty NG, Yamasaki S, et al. (1995). Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl Acad. Sci. U.S.A.92: 8078–8082. ArticleCASPubMedPubMed Central Google Scholar
Salgaller ML, Weber JS, Koenig S, Yannelli JR, Rosenberg SA. (1994). Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. Cancer Immunol Immunother.39: 105–116. ArticleCASPubMed Google Scholar
Dranoff G, Jaffee E, Lazenby A, et al. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity. Proc. Natl Acad. Sci. U.S.A.90: 3539–3543. ArticleCASPubMedPubMed Central Google Scholar
Riviere I, Brose K, Mulligan RC. (1995). Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl Acad. Sci. U.S.A.92: 6733–6737. ArticleCASPubMedPubMed Central Google Scholar
Danos O, Mulligan RC. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl Acad. Sci. U.S.A.85: 6460–6464. ArticleCASPubMedPubMed Central Google Scholar
Rahemtulla A, Fung-Leung WP, Schilham MW, et al. (1991). Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature353: 180–184. ArticleCASPubMed Google Scholar
Fung-Leung WP, Schilham MW, Rahemtulla A, et al. (1991). CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell65: 443–449. ArticleCASPubMed Google Scholar
Tang DC, De Vit M, Johnston SA. (1992). Genetic immunization is a simple method for eliciting an immune response. Nature356: 152–154. ArticleCASPubMed Google Scholar
Ulmer JB, Donnelly JJ, Parker SE, et al. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science259: 1745–1749. ArticleCASPubMed Google Scholar
Conry RM, Lo Buglio AF, Loechel F, et al. (1995). A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity. Gene Ther.2: 59–65. PubMedCAS Google Scholar
Wang B, Merva M, Dang K, Ugen KE, Williams WV, Weiner DB. (1995). Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Hum. Gene Ther.6: 407–418. ArticleCASPubMed Google Scholar
Major ME, Vitvitski L, Mink MA, et al. (1995). DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J. Virol69: 5798–5805. PubMedPubMed CentralCAS Google Scholar
Levitsky HI, Lazenby A, Hayashi RJ, Pardoll DM. (1994). In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression. J. Exp. Med.179: 1215–1224. ArticleCASPubMed Google Scholar
Inaba K, Inaba M, Romani N, et al. (1992). Generation of large numbers of dendritic 555 cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med.176: 1693–1702. ArticleCASPubMed Google Scholar
Guery JC, Adorini L. (1995). Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol.154: 536–544. PubMedCAS Google Scholar
Steinman RM. (1991). The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol.9: 271–296. ArticleCASPubMed Google Scholar
Allison JP. (1994). CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol.6: 414–419. ArticleCASPubMed Google Scholar
Boon T, Coulie P, Marchand M, Weynants P, Wolfel T, Brichard V. (1994). Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. In: DeVita VT, Hellmann S, Rosenberg SA (eds). Important Advances in Oncology. J.B. Lippincott Company: Philadelphia, pp. 53–69. Google Scholar
Repique CJ, Kettering JD, Gridley DS. (1992). Immunosuppression derived from human B-lymphoblastoid and melanoma cell lines. Cancer Invest.10: 201–208. ArticleCASPubMed Google Scholar
Young MR, Wright MA, Coogan M, Young ME, Bagash J. (1992). Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta. Cancer Immunol. Immunother.35: 14–18. ArticleCASPubMed Google Scholar
Kuppner MC, Hamou MF, Bodmer S, Fontana A, de Tribolet N. (1988). The glioblas-toma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int. J. Cancer42: 562–567. ArticleCASPubMed Google Scholar
Mizoguchi H, O’Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. (1992). Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice [see comments]. Science258: 1795–1798. ArticleCASPubMed Google Scholar
×iang Z, Ertl HC. (1995). Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity2: 129–135. ArticlePubMed Google Scholar
Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH. (1993). Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. U.S.A.90: 5687–5690. ArticleCASPubMedPubMed Central Google Scholar
Townsend SE, Allison JP. (1993). Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science259: 368–370. ArticleCASPubMed Google Scholar
Hodge JW, McLaughlin JP, Abrams SI, Shupert WL, Schlom J, Kantor JA. (1995). Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. Cancer Res.55: 3598–3603. PubMedCAS Google Scholar
Kuchroo VK, Das MP, Brown JA, et al. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Thl/Th2 developmental pathways: application to autoimmune disease therapy. Cell80: 707–718. ArticleCASPubMed Google Scholar
Seder RA, Paul WE. (1994). Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev. Immunol.12: 635–673. ArticleCASPubMed Google Scholar
Wu TC, Huang AY, Jaffee EM, Levitsky HI, Pardoll DM. (1995). A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med.182: 1415–1421. ArticleCASPubMed Google Scholar
Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. (1994). Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science264: 961–965. ArticleCASPubMed Google Scholar
Pardoll DM. (1994). Tumour antigens. A new look for the 1990s [news; comment]. Nature369: 357. ArticleCASPubMed Google Scholar
zur Hausen H, and de Villiers EM. (1994). Human papillomaviruses. Annu. Rev. Microbiol.48: 427–447. ArticlePubMed Google Scholar
Rubin SC, Finstad CL, Federici MG, Scheiner L, Lloyd KO, Hoskins WJ. (1994). Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer. Cancer73: 1456–1459. ArticleCASPubMed Google Scholar